Fool.com
The World's Greatest Investing Community
Results 11 - 20 of 425 : Previous 1 2 3 4 5 6 7 8 9 Next
Medical devices and diagnostics pass by drugs as the main revenue source.
Healthy Spinoffs, Happy Investors
When medical companies spin off unwanted divisions, the spinoffs can outperform the parent.
Companies to help you cope with market volatility.
For Drugmakers, It's All In or Get Out
The Solvay-Abbott deal illustrates why conglomerates are getting out of the prescription-drug business.
History is not on Merck and Schering's side.
Abbott Labs Looks Less Lopsided
The pharma scores a nice medium-sized pickup.
Psoriasis is no match for this powerhouse.
The World's Best Dividend Stocks
Don't limit yourself to U.S. blue chips.
What Would You Do for a 90% Profit?
Would you work longer? Would you retire later?
Pfizer and Wyeth Put the Horse Before the Cart
The pharmas' animal-business divestiture brings them one step closer to unity.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK